Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 33 matches.
Page:
1
Refine your search to narrow the results.

Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment

J Am Acad Dermatol 2014 Dec; 71(6): 1183-1190 [Epub 2014 Oct 11]. PMID: 25313095 / doi: 10.1016/j.jaad.2014.08.039

Journal
Journal of American Academy of Dermatology (JAAD)
PubMed ID
25313095
Condition
Psoriasis
Author
Kim Papp, Craig Leonardi, Alan Menter, Elizabeth H. Z. Thompson, Cassandra E. Milmont, Greg Kricorian, Ajay Nirula, Paul Klekotka
Year
2014
Register & Request Access

Management of Dermatologic and Gastrointestinal Adverse Events Associated With Tyrosine Kinase inhibitors Therapy in NSCLC

Presented by Dr. Kim Papp, Regional Cancer Center, 18-Dec-2014

Condition
Cutaneous AEs
Author
Dr. Kim Papp
Year
2014
Register & Request Access

Highly Sensitive and Drug Tolerant Immunogenicity Screening Assay for Ixekizumab, an Anti-IL-17A Antibody, Using an Affinity Capture Elution Approach

Presented at 7th International Congress Psoriasis From Gene to Clinic in London, United Kingdom, December 11-13, 2014

Condition
Psoriasis
Author
Talia M. Muram, John H. Sloan, Jana S. Chain, Wendy J. Komocsar, Bruce I. Meiklejohn, Andy Blauvelt, Kim Papp, Kenneth Gordon, Michael P. Heffernan, and Robert J. Konrad
Year
2014
Register & Request Access

AMAGINE-1: a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Brodalumab in Subjects With Psoriasis

Presented at 7th International Congress Psoriasis From Gene to Clinic in London, United Kingdom, December 11-13, 2014

Condition
Psoriasis
Year
2014
Register & Request Access

Addressing Your and Your Patient's Therapeutic Concerns

Presented at PILLARS, Montreal, Quebec, Canada, November 8, 2014

Condition
Psoriasis
Author
Kim A. Papp
Year
2014
Register & Request Access

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: results of phase 3, randomized, placebo-controlled trials

Presented at 23rd Congress of the EADV, Amsterdam, The Netherlands, Oct 2014.

Condition
Psoriatic Arthritis
Author
Chimenti S, Blanco FJ, Behrens F, Kavanaugh A, Papp K, Stevens RM, Hu C, Edwards CJ
Year
2014
Register & Request Access

Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, on Clinical Signs of Moderate-to-Severe Plaque Psoriasis in Different Body Regions

Journal of Drugs Dermatology. 2014 Mar 1; 13(3): 252-6. PMID: 24595567

Journal
Journal of Drugs in Dermatology
PubMed ID
24595567
Condition
Psoriasis
Author
Alan Menter, Kim A. Papp, Huaming Tan, Steve Tyring, Robert Wolk, Marjorie Buonanno
Year
2014
Register & Request Access

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis: Results of Phase 3, Randomized, Placebo-Controlled Trials (PALACE 1, 2, and 3)

Presented at 42 Kongress der Deutschen Gesellschaft fur Rheumatologie (DGRh); 17-20 September 2014; Dusseldorf, Deutschland.

Condition
Psoriatic Arthritis
Author
Georg Schett, Sergio Chimenti, Francisco J. Blanco, Frank Behrens, Arthur Kavanaugh, Kim Papp, Randall M. Stevens, ChiaChi Hu, Christopher J. Edwards
Year
2014
Register & Request Access

Effects of Apremilast on Pruritus in Patients With Moderate to Severe Plaque Psoriasis: Results From the ESTEEM 1 and 2 Trials

Presented at Society of Dermatology Physician Assistants 12th Annual Fall Dermatology Conference. 12-15 November 2014

Condition
Psoriasis
Author
Kim Papp, Gil Yosipovitch, Jerry Bagel, Leon Kircik, Diamant Thaci, Jo Lambert, Carlos Ferrandiz, Mark Goodfield, ChiaChi Hu, Randall M. Stevens, Robert M. Day, Giampiero Girolomoni
Year
2014
Register & Request Access

New agents under development for autoimmune disease

Presented by Dr. Melinda Gooderham, Interdisciplinary Autoimmune Summit, Last Vegas, June 22, 2014.

Condition
Autoimmune Disease
Author
Dr. Melinda Gooderham
Year
2014
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login